Literature DB >> 23036261

Plasmablastic lymphoma in pediatric patients: clinicopathologic study of three cases.

Sugeshnee Pather1, Diane MacKinnon, Rushen S Padayachee.   

Abstract

Plasmablastic lymphoma (PBL) is an aggressive high grade non-Hodgkin lymphoma which occurs predominantly in adult patients who are concomitantly afflicted with HIV infection. In contrast to several reports and studies of PBL in adult patients, PBL has very rarely been reported in pediatric patients. This article hereby provides collaborative clinicopathologic information of de novo PBL diagnosed in 3 pediatric patients with concomitant HIV infection. Cognizance of this rare tumor in the pediatric population coupled with antiretroviral therapy and prompt initiation of multimodality treatment may, in the future, facilitate improved outcome in pediatric patients with PBL.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 23036261     DOI: 10.1016/j.anndiagpath.2012.08.005

Source DB:  PubMed          Journal:  Ann Diagn Pathol        ISSN: 1092-9134            Impact factor:   2.090


  5 in total

1.  Let's face it - 13 unusual causes of facial masses in children.

Authors:  Jacqueline du Toit; Nicole Wieselthaler
Journal:  Insights Imaging       Date:  2015-07-20

Review 2.  Plasmablastic Lymphoma: A Review of Current Knowledge and Future Directions.

Authors:  Ghaleb Elyamany; Eman Al Mussaed; Ali Matar Alzahrani
Journal:  Adv Hematol       Date:  2015-08-18

Review 3.  Current knowledge on HIV-associated Plasmablastic Lymphoma.

Authors:  Michele Bibas; Jorge J Castillo
Journal:  Mediterr J Hematol Infect Dis       Date:  2014-11-01       Impact factor: 2.576

4.  Tibial Plasmablastic Lymphoma in a HIV-Negative Child: A Novel Extraoral Localisation.

Authors:  Ali Mala; Yameena Noman Khan; Akbar Ahmed; Naema Khayyam; Kanwal Aftab
Journal:  Case Rep Hematol       Date:  2022-06-08

Review 5.  Plasmablastic lymphoma: An update.

Authors:  Jenique Bailly; Nicholas Jenkins; Dharshnee Chetty; Zainab Mohamed; Estelle R Verburgh; Jessica J Opie
Journal:  Int J Lab Hematol       Date:  2022-09       Impact factor: 3.450

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.